LOPERAMIDE EG CONSEIL 2 mg, orodispersible tablet 12 tablets, CIP 3400930314487
Active ingredients: Loperamide hydrochloride
Commercialized according to BDPM
Orodispersible tablet12 tablets, CIP 3400930314487orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LOPERAMIDE EG CONSEIL 2 mg, comprimé orodispersible
- Pharmaceutical form
- comprimé orodispersible
- Route of administration
- orale
- Presentation description
- 12 plaquette(s) perforée(s) aluminium de 1 comprimé(s)
- Marketing authorisation holder
- EG LABO - LABORATOIRES EUROGENERICS
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 6 Oct 2026
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66227760CIP73031448CIP133400930314487Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE LOPÉRAMIDEcomprimé | 2,00 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.